[1] |
Soni M, Gopalakrishnan R, Vaishya R, et al. D-dimer level is a useful predictor for mortality in patients with COVID-19: analysis of 483 cases. Diabetes Metab Syndr, 2020; 14, 2245−9. doi: 10.1016/j.dsx.2020.11.007 |
[2] |
Rostami M, Mansouritorghabeh H. D-dimer level in COVID-19 infection: a systematic review. Expert Rev Hematol, 2020; 13, 1265−75. doi: 10.1080/17474086.2020.1831383 |
[3] |
Gungor B, Atici A, Baycan OF, et al. Elevated D-dimer levels on admission are associated with severity and increased risk of mortality in COVID-19: a systematic review and meta-analysis. Am J Emerg Med, 2021; 39, 173−9. doi: 10.1016/j.ajem.2020.09.018 |
[4] |
Mihaila RG, Mihaila MD. Coagulation disorders in SARS-CoV-2 infection. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub, 2020; 164, 226−35. doi: 10.5507/bp.2020.037 |
[5] |
Bauer W, Galtung N, Neuwinger N, et al. A matter of caution: coagulation parameters in COVID-19 do not differ from patients with ruled-out SARS-CoV-2 infection in the emergency department. TH Open, 2021; 5, e43−55. doi: 10.1055/s-0040-1722612 |
[6] |
Levi M, van der Poll T. Coagulation and sepsis. Thromb Res, 2017; 149, 38−44. doi: 10.1016/j.thromres.2016.11.007 |
[7] |
Wong JP, Viswanathan S, Wang M, et al. Current and future developments in the treatment of virus-induced hypercytokinemia. Future Med Chem, 2017; 9, 169−78. doi: 10.4155/fmc-2016-0181 |
[8] |
Zinellu A, Paliogiannis P, Carru C, et al. INR and COVID-19 severity and mortality: a systematic review with meta-analysis and meta-regression. Adv Med Sci, 2021; 66, 372−80. doi: 10.1016/j.advms.2021.07.009 |
[9] |
Akama-Garren EH, Li JX. Unbiased identification of clinical characteristics predictive of COVID-19 severity. Clin Exp Med, 2022; 22, 137−49. doi: 10.1007/s10238-021-00730-y |